Concord Wealth Partners - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$12,601
-10.6%
4680.0%0.00%0.0%
Q2 2023$14,100
-6.9%
4680.0%0.00%
-25.0%
Q1 2023$15,149
+12.9%
4680.0%0.00%0.0%
Q4 2022$13,421
+3.2%
468
+1.5%
0.00%0.0%
Q2 2022$13,000
-27.8%
4610.0%0.00%
-20.0%
Q1 2022$18,000
+20.0%
4610.0%0.01%
+25.0%
Q4 2021$15,0004610.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2022
NameSharesValueWeighting ↓
New Harbor Financial Group, LLC 1,221,955$36,011,00014.81%
New Harbor Financial Group, LLC 1,155,900$34,064,00014.01%
Memorial Sloan Kettering Cancer Center 738,500$21,764,00013.56%
Hollow Brook Wealth Management LLC 670,275$19,753,00012.24%
Grand Central Investment Group 293,243$8,642,00011.46%
BW Gestao de Investimentos Ltda. 940,800$27,725,0008.44%
Slate Path Capital LP 5,930,000$174,757,0007.97%
Nokomis Capital, L.L.C. 512,628$15,107,0007.14%
Plaisance Capital LLC 288,000$8,487,0006.05%
Guild Investment Management, Inc. 200,114$5,897,0005.68%
View complete list of VANECK VECTORS ETF TR shareholders